Gerresheimer AG
ISIN: DE000A0LD6E6
WKN: A0LD6E
20 November 2025 01:18PM

EQS-News: Gerresheimer AG: Change in the Supervisory Board

Gerresheimer AG · ISIN: DE000A0LD6E6 · EQS - Company News
Country: Germany · Primary market: Germany · EQS NID: 2233454

EQS-News: Gerresheimer AG / Key word(s): Personnel
Gerresheimer AG: Change in the Supervisory Board

20.11.2025 / 13:18 CET/CEST
The issuer is solely responsible for the content of this announcement.


Gerresheimer AG: Change in the Supervisory Board

  • Klaus Röhrig succeeds Dr. Dorothea Wenzel
  • Composition of the Supervisory Board reflects the changed shareholder structure
     

Duesseldorf, November 20, 2025. Klaus Röhrig, co-founder and Co-Chief Investment Officer of the Active Ownership Group, has been appointed to the Supervisory Board of Gerresheimer AG until the next Annual General Meeting in June 2026. He succeeds Dr. Dorothea Wenzel, who made her position available  to reflect the changed shareholder structure of the company in the composition of the Supervisory Board. With his appointment, Klaus Röhrig also assumes the duties of Dr. Dorothea Wenzel on the Audit Committee of Gerresheimer AG.
 

“We sincerely thank Dr. Dorothea Wenzel for her dedicated work on the Supervisory Board and the Audit Comittee,” says Dr. Axel Herberg, Chairman of the Supervisory Board of Gerresheimer AG. “With her expertise and experience, she has made an significant contribution to the fulfillment of the committee’s duties.”
 

Annual General Meeting on June 3, 2026

Klaus Röhrig will stand for election to the Supervisory Board at the next Annual General Meeting on June 3, 2026. In total, four shareholder representatives will be up for election at the next Annual General Meeting of Gerresheimer AG’s co-determined Supervisory Board.
 

About Gerresheimer 
Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The Group offers a comprehensive portfolio of drug containment solutions including closures and accessories, as well as drug delivery systems, medical devices and solutions for the health industry. The product range includes digital solutions for therapy support, on-body devices, syringes, pens, auto-injectors and inhalers as well as vials, cartridges, ampoules, tablet containers, infusion, dropper and syrup bottles and more. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient. Gerresheimer supports its customers with comprehensive services along the value chain and in addressing the growing demand for enhanced sustainability. With over 40 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets. Together with Bormioli Pharma, the Group generated revenues of around EUR 2.4bn in 2024 and currently employs around 13,600 people. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).    
www.gerresheimer.com 
 

Contact Gerresheimer

Media  
Jutta Lorberg
Head of Corporate Communication
T +49 211 6181 264
jutta.lorberg@gerresheimer.com       
Dersim Korkmaz
Corporate Communication
T +49 211 6181 296
dersim.korkmaz@gerresheimer.com   
 
Investor Relations
 
Guido Pickert
Vice President Investor Relations
T +49 211 6181 220
gerresheimer.ir@gerresheimer.com
 
 


20.11.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Gerresheimer AG
Peter-Müller-Str. 3
40468 Duesseldorf
Germany
Phone: +49-(0)211/61 81-00
Fax: +49-(0)211/61 81-121
E-mail: gerresheimer.ir@gerresheimer.com
Internet: http://www.gerresheimer.com
ISIN: DE000A0LD6E6
WKN: A0LD6E
Indices: MDAX (Aktie)
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2233454

 
End of News EQS News Service

2233454  20.11.2025 CET/CEST

Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.

The most important financial data at a glance
  2019 2020 2021 2022 2023 2024 2025e
Sales1 1.392,26 1.418,79 1.498,01 1.817,09 1.990,49 2.035,90 1.974,00
EBITDA1,2 400,01 310,14 306,31 340,87 399,42 396,00 368,00
EBITDA-Margin3 28,73 21,86 20,45 18,76 20,07 19,45 18,64
EBIT1,4 123,76 156,46 147,44 169,31 213,39 197,47 175,00
EBIT-Margin5 8,89 11,03 9,84 9,32 10,72 9,70 8,87
Net Profit (Loss)1 82,68 89,88 87,24 102,19 120,09 112,32 76,00
Net-Margin6 5,94 6,34 5,82 5,62 6,03 5,52 3,85
Cashflow1,7 192,92 222,19 212,08 221,94 294,34 240,33 0,00
Earnings per share8 2,57 2,82 2,67 3,06 3,48 2,56 2,10
Dividend per share8 1,20 1,25 1,25 1,25 1,25 0,04 0,50
Quelle: boersengefluester.de and Company information
Explanation

1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de

Auditor: KPMG

All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.

INVESTOR-INFORMATION
©boersengefluester.de
Gerresheimer
WKN ISIN Legal Type Marketcap IPO Recommendation Plus Code
A0LD6E DE000A0LD6E6 AG 906,33 Mio € 11.06.2007 Halten 9F387QF9+73
* * *
PE 2026e PE 10Y-Ø BGFL-Ratio Shiller-PE PB PCF KUV
10,29 23,13 0,44 7,97 0,60 3,77 0,45
Dividends
Dividend '2023
in €
Dividend '2024
in €
Dividend '2025e
in €
Div.-Yield '2025e
in %
1,25 0,04 0,50 1,93%
Financial calendar
Annual General Meeting Q1-figures Q2-figures Q3-figures Annual press conference
03.06.2026 16.04.2026 14.07.2026 10.10.2025 26.02.2026
Performance
Distance 60-days-line Distance 200-days-line Performance YtD Performance 52 weeks IPO
Last Price (EoD)
-1,45%
25,86 €
ATH 122,90 €
-14,48% -45,57% -63,58% -65,52% -35,35%

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2025          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2025 by Gereon Kruse #BGFL